Role of angiotensin II receptor blockers in atherosclerotic plaque stability. (Q36382568)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Role of angiotensin II receptor blockers in atherosclerotic plaque stability.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Europe PubMed Central

Role of angiotensin II receptor blockers in atherosclerotic plaque stability (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

atherosclerosis

1 reference

based on heuristic

inferred from title

Francesco Cipollone

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Maria Luigia Fazia

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Andrea Mezzetti

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

0 references

publication date

1 February 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

277-285

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Current concepts of the pathogenesis of the acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Vascular and cardiac benefits of angiotensin receptor blockers

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Reactive oxygen species in the vasculature: molecular and cellular mechanisms

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Angiotensin AT1/AT2 receptors: regulation, signalling and function

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Collagen synthesis in atherosclerosis: too much and not enough

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Coxibs and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

COX-2 inhibitors--a lesson in unexpected problems

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.277

21 January 2018

Identifiers

10.1517/14656566.7.3.277

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36382568&oldid=1519026284"